Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did anyone see Bruce Patterson was granted 569,242 shares, and before the Covid results he sold a ton leaving him with 169,242.
Seems really shady. He is compensated? He then sold 400k shares before the trial results?
I did do well, I got out with a small loss. Sorry, maybe if you listened and didn't drink the kool aid you would have too.
I want to congratulate Nader!!!!!
Nader - Congrats!
You have achieved an amazing feat Sir. You get paid 7 figures, look like you are homeless on youtube daily, and in all these years have taken a drug acquired for pennies and used the "story" to pull ($245,638,232) dollars from shareholders as of your August 10-Q.
Amazing ability to take a stock like CYDY and create your own personal ATM machine, deliver absolutely no shareholder value, and continue to make up fantasy stories daily on youtube.
You Sir are truly amazing! I hope all shareholders congratulate you for an amazing ride that will continue perpetually as I am sure the next "deal" is only 10 days away. :)
Since the shareholder deficit as of August 2019 was $245,638,232.00 and you will need to dilute again in order to make payroll so the shareholders can cover your salary and pay for your penny stock promotions on youtube what will be the next amount of deficit? $300,000,000?
How is that deal that was supposed to come in 10 days over 60 days ago coming along? lol
Let me guess, your CEO was too busy paying penny stock news channels on youtube daily to pump up the stock from .30 to .31 cents versus getting the deal signed. Seems like a good use of shareholder dollars. Don't shave, look like a degenerate on camera, collect a $1,000,000 compensation package, make videos on youtube daily, and pretend your drug will cure everything from HIV to Ebola while promising shareholders an imaginary deal is right around the corner.
LOL. Yea, that won't happen - I can assure you. Best of luck on "hoping" this happens. Last I checked "hope" isn't a strategy, especially when dealing with pure embellishments and made up fantasy stories.
World Aids Day? LMAO. Yes, and maybe Venus will align with Mars, the wind will blow south to north, and your CEO degenerate will actually admit for once he is full of pure crap. You people are completely, and totally, clueless.
By the way, for the clowns posting theories on whether/whether not a company needs to make public a formal offer - yes, they do. Which is why, CYDY has never once received a formal offer. If a formal offer was in fact issued for the company, then the Board must make shareholders aware.
Last I checked, no SEC filing was ever made on an "offer" for the company. The only offer received was the imaginary stories your CEO makes on youtube while you pay his salary and you pay for the penny stock promotion "news" people to pump your company - seeing that you are still on the OTC board, still in a downtrend, and still living in fantasy land this will ever become some thing I would say the money you are spending on pumping this is a complete and total waste. :)
How's that 10 days till a deal that was supposed to come a month ago working out for you? lol
Have any shareholders...............
Looked up what your CEO has spent in the past 12 months pumping his false promises on penny stock stations like Proactive Investors. You do realize these services are not free, and no - lol it is not real news nor a real channel genuinely interested in your pumped penny stock. Everytime your CEO goes on YouTube you, as a shareholder, are paying for his weak attempt almost daily to prop up the stock so it doesn't fall even lower. Pretty sad.
Nader.........
When you go on YouTube tomorrow to spew more pump garbage that won't come to pass, can you at least look like you tried to look professional? Daily on YouTube you look like you rolled out of bed at noon after being at the bar all night.
Take some pride in yourself. If you are going to pump fake deals and missed FDA promises at least look half decent while doing it. You got a good penny stock gig going here, try to look the part for goodness sake. Go to walmart and buy yourself a razor and shave and shower before your next penny stock paid promotion show tomorrow.
When were they supposed to report? Seems really odd. Is there like a due date or something or is it whenever they feel like it?
Does anyone know when this PTAB ruling is coming!?!? Seems, from what little I know, to be very delayed / behind schedule. Thanks
New here....
But, I did see the CEO gave up a $150,000,000 deal because he believes in the company so much - seems very bullish.
Anyone know where things are in the lawsuit against Apple? He must have turned down the deal because a favorable ruling from the courts are coming.
you are welcome. I called yesterday to ask a question and the number was disconnected. Tried again this morning, same thing.
The phone number to the company is disconnected. Try it. They will be shutting this down any day now.
Dear Fellow Shareholder,
Since my last letter, we have achieved great strides in the development of our flagship product, the DenerveX™ System. These efforts recently culminated in our official receipt of both ISO 13485 Certification and CE Mark approval for the DenerveX System allowing for the Company to now commence selling and marketing the DenerveX System in Europe and other countries that accept the CE Mark. Years in the making, this milestone event officially marks the company's transition from a development stage company to a commercialization stage company.
Initial orders received:
Since receiving CE Mark, we have received orders for the DenerveX Kits and the DenerveX Pro-40 generators from TCB Distribution Center in Berlin, Germany, as well as orders from TCB Ortho, our Germany distributor and EDGE Medical in the Manchester, England.
First in human cases:
We are pleased to announce that three centers in the EU will perform our first in human cases for the DenerveX System. They include hospitals in Manchester, England; Stuttgart, Germany and Potsdam, Germany with committed initial DenerveX System Cases of ten patients at each center. These cases are scheduled to begin in July.
The DenerveX System is designed to provide longer term relief from debilitating pain associated with Facet Joint Syndrome (FJS). Lower back pain (LBP) remains the second most common cause of disability in the U.S., and affects approximately 10% of adults. Studies indicate that that 31% of lower back pain cases are attributed to FJS.
The DenerveX System consists of the single use DenerveX Kit containing the DenerveX Device, powered by the dedicated DenerveX Pro-40 generator. The system represents a highly disruptive product targeting a large and expanding market opportunity. Importantly, it was specifically designed by surgeons for surgeons, to be less invasive with faster recovery time than current surgical treatment options, while also providing for a longer lasting treatment solution and offering potential savings to the health care system.
A presentation published by Roger Chou, MD, and Associate Professor of Medicine at Oregon Health and Science University, indicated that lower back pain is the fifth most common reason for U.S. doctor office visits, and the second most common symptomatic reason. The presentation indicated that that there is an estimated greater than $100 billion dollars in total health care expenditures for LBP in the U.S. It further cited LBP as the most common cause for activity limitations in persons under the age of 45. The presentation further goes on to discuss the growing epidemic of Opioid addiction related to increased physician prescribing patterns for pain management. Our DenerveX System was specifically designed to address long term pain management seeking to alleviate, and or mitigate pain, in addition to potentially reducing dependence on pharmaceutical based remedy.
The EU launch scope and size:
The team has worked very effectively in securing twelve separate distribution agreements that cover 19 countries mostly in the EU, and a few limited countries in Asia Pacific and Latin America that accept the CE Mark. Our plans are to conduct a controlled pilot launch in the UK and Germany to validate and verify the elements of the launch plan by approaching the market with key opinion leaders in high volume centers. Our plan is to go "narrow and deep" with a few selected high volume key opinion leaders initially. Our pilot will include the UK and Germany followed by designated countries for a controlled launch managing risk while maximizing opportunity in a very sizable market in the EU. Our launch plans are complete and fully covering in scope for all sales, marketing and distribution areas.
NSpine-Launch Meeting-June 12-15, 2017:
This week, our team will be in attendance at The NSpine Main Conference in London, UK where we will be conducting a DenerveX System cadaver lab and work shop lecture with leading spine surgeon and advisory board member Dr. Vik Kapoor. The NSpine show will be an excellent meeting venue to meet with key surgeons. The UK market is very important to us since it will be a leading market for our initial entry into Europe on the heels of receiving the CE Mark.
As part of our European sales launch, I'd like to highlight a few objectives we are actively initiating. A key aspect of our sales initiative is obviously physician training and education. Our objective is to optimize physician training for positive patient treatment outcomes, procedural reproducibility and efficiency for the treatment of Facet Joint Syndrome with the DenerveX System. The DenerveX procedure is taught in a step-by-step reproducible industry standard method, using tools provided by Medovex and their highly skilled and experienced trainers through DenerveX lecture and observation of actual patient cases.
Launch and rollout physician training strategy:
We have planned a highly effective and historically proven customer training process used throughout the industry. We will offer peer-to-peer DenerveX training sessions for physicians at a "DenerveX University" designated training site in the EU. This advanced clinical training is a physician-led program to address any clinical questions regarding this innovative technology. These training physicians have been selected based on their passion and experience in the DenerveX approach.
As we transition from a development focused organization to a revenue generating company, I'm keenly aware that being a public company involves the management of not just our actual fundamental business, but also the public markets, compliance with trading exchanges, and investor communications.
With this in mind, I want to touch on the Company's recently received Nasdaq deficiency letter, details of which may be found in a Form 8K filed with the SEC. I want you to know that we are taking the notification very seriously and have engaged a strategic consultant proficient in advising companies in similar situations to help us formulate and propose a plan to regain compliance. We have a hearing with Nasdaq on June 15th to discuss the matter. It is fully our intent to do whatever is necessary to comply and satisfy the matter to preserve our listing on the exchange.
Regarding the current valuation of the company and its shares, I am not satisfied. I believe our stock is significantly undervalued relative to other medical device companies, and especially in light of what many would consider a transformational event; receipt of both ISO Certification and CE Mark. I think it's important to note that my team and I have real world experiencing in building businesses into profitable enterprises. I personally built my last company from a single office with just four employees, into two hundred and seventy offices located in four states, and employing over five hundred people. I am dedicated to doing the same here by taking our product and building a business that is expected to provide return on investment for all of our shareholders. Again, the DenerveX System was designed for surgeons by surgeons in an effort to address long term pain management.
My personal conviction and commitment, along with other insiders, can be no better evidenced than by reviewing an already long and growing list of repeated insider purchases memorialized in Form 4's filed with the SEC. You will note that I just personally bought additional shares, along with the Company's co-founder, since the announcement of our receipt of ISO Certification and CE Mark approval. In addition, board member and DenerveX Device inventor Dr. Scott Haufe also made significant purchases in recent months. I believe it is important that we lead by example, putting our own money where our mouth is. Recent filings can only be seen for what they are, again an affirmation of our commitment and belief in both our team and the opportunity.
In closing, while I want to thank all of you as our shareholders, I want to especially thank the entire Medovex team. Together, we've taken a concept to a commercial product and are now entering a growth stage that we've all been working towards for the last two years. While we continue to have a lot of work ahead of us as we focus on driving adoption and revenue, I have confidence that we will excel in achieving our future goals, much like we did in getting here today.
"Better living through better medicine" is not just a slogan; it's a philosophy that management and our board are committed to seeing through in the form of innovative new products like our DenerveX Device. Thank you again for your valued support.
Kind regards,
Jarrett Gorlin
Chief Executive Officer
About Medovex
Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX System, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. The DenerveX System is CE Marked while not yet FDA approved. To learn more about Medovex Corp., visit www.medovex.com.
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
CONTACT INFORMATION
Medovex Corp.
Jason Assad
470-505-9905
Email Contact
Good thing for me, I just bought another 10K. Keep knocking the stock down, please!
There is nothing in your links to cause this... The company has an amazing Board, impressive management team, very very very strong insider buying, a product now approved in the EU, and lastly is worth at least three times the current share price.
The company already has interest in the product, is attending in a week the premier conference for their specialty, and yesterday's move in share price is in no way reflective of the true value.
A large investor (for a nano-cap like this large is a few hundred thousand shares) sold. Why? Not sure. However, he/she did. This caused a massive sell off.
This will be up 20% by the end of the week.
Medovex is going to be huge! CE Mark is so close I can smell it!
Uh, Tony....
I hate to break it to you, CYDY could be out of business before the end of the year. They have no money. No real plan on how to get money. Well besides diluting the shareholders more.
Sure would be nice if certain people on the executive team took a pay cut.
LOL....
Really? 16 dollars huh? Is that before, during, or after the golden quarter from Nader? If it will be $16 - then you call the Dr back, and tell him he should back up the truck and buy every share he can.
Wait, that's right... Per the mysterious attorney no one is allowed to buy shares internally.
When the attorney said no one internally can buy, you should have asked Nader directly why then when he could buy in October of last year he only spent $7,000. I mean certainly for a drug that could cure the world's problems, and with his hefty compensation spanning 15 years he could come up with more than $7,000.
Tell me....
Since Nader (being the good guy he is) is so concerned for your wealth, and knowing he destroyed the company's financials - how come he hasn't taken a reduction in salary?? Wait, he must be saving his money to buy shares 45 years from now when his lawyer doesn't call it "insider trading" lol
The meeting......
While all that news sounds quite intriguing:
1: What kind of scam excuse from that attorney was the "insider trading" mumbo jumbo. Executives daily buy their own stock. Nader has had 15 years to buy his own stock. I don't believe it.
2: Who did most of the talking? If it was Nader, then it was irrelevant.
3: Out of millions of people supposedly desperate for a new HIV treatment - they can't find 30???? Hello!!
15 years. In 15 years what have they accomplished? Nothing. Absolutely nothing. Nader keeps getting paid, he keeps selling everyone how right around the corner this magical "golden" month, quarter, year will happen, and he keeps selling how great everything is.
This is a classic stock scam. Plain and simple. Legitimate companies with a real product and a real senior management team do not behave this way.
Here is one for you, IF Pro 140 is what "they" say it is, how come no partner? I can think of hundreds of biotechs who have large pharma partners. No partner, nothing. If this was what "they" claim, how come no real insider buying? 15 years. not 3, not 7, 15.
I sold my shares in CYDY last week for a loss. Now, I am here to help and try to make sure other people aren't suckered into this fantasyland story.
Could be because of the SEC, just like Venus could align with Mars, the wind could blow north to south, and the sun could blow up tomorrow causing the world to end.
Face it... they aren't buying the stock because IF pro 140 does work it will take another 15 years to get anywhere. Plus, that is a big IF.
In the last 12 months this is your "insider buying"
Transaction Type / Date Current Average
6 Month Return Shares /
Market Value Price Range Total Holdings
Insider information is updated as it is received from the data provider.
Mulholland Michael D
Purchase
10/17/2016
-- 11.0K
$7.2K $0.66 - $0.66 37,043
Naydenov Jordan G
Award of Stock Options
5/10/2016
-- 1.0M
$0 $0.00 - $0.00 5,097,242
Pourhassan Nader
Purchase
10/21/2016
-- 15.0K
$9.9K $0.66 - $0.66 75,806
If I were going to save the world from AIDS, I would sell everything to buy my own company's stock.
what insider buying? There has been NO insider buying. NONE. ZERO. Besides a few token purchases by nader and the CFO none of these people have any vested interest here besides collecting their salary.
15 years. Let me repeat, 15 years. Nothing. Zero. No real tangible movement. You could walk from Maine to California 180,000 times with one leg and be half blind in the time it has taken for CYDY management to announce another Board member with no relevance to the product/company.
Your CEO. If you notice his personal email address is on there early in the video. Perhaps he will update you people with an email there since he wont update you in public like he should.
Now I am happy....
Happy I sold this stock, even for a loss.
Here is a video on youtube where your CEO (formerly mine) was selling his snakeoil even 5 years ago!
Go to 2:42 on the video and hear how he dangles a partnership out there - again 5 years ago!
So there is only one person who questions this management team? I believe in the product, I don't believe in our management. How can you? They continually promise and not deliver. I mean how hard is it to under promise and over deliver? If our CEO wanted to be credible he would have said: The results will be in the second half of 2017. Not some golden quarter fluff.
If he would have said second half, and the results came in first half he would have been in a hero. If they came in second half, he would have been credible and sound.
Now, he is just a salesman who will promise anything. How can I believe anything?
You know what, I just decided you are right. I am out. Will be selling my shares today for a loss, and putting the funds in something more appropriate.
Good luck to all of you.
How about instead of making fun of me, accusing me of being someone I am not, and completely disregarding my very fair, appropriate, and clear criticism of our current management - you actually muster together a thought provoking post on WHY I am wrong?
Please tell me, show me, prove to me why I am wrong. Please show me. I really would appreciate something more than wisecrack jokes. Thanks
Sorry Paul. I promise you I am not this guy. I also promise you I wish I didn't purchase shares in this fantasy company. However, I let emotion get the best of me. If I would have looked at the fundamentals, I would have been on my way without CYDY.
Do I hope this hits? Of course I do. Financially and for the good of mankind.
Do I believe it will hit? Nope.
Sorry.
No clue who this pearsby guy is. I am just a simple private investor with 4000 shares in this company. I am also a very pragmatic, logical, and very suspect thinker.
I see nothing but holes, gaps, and fantasy stories here with CYDY. Am I holding my shares? Yes, I have to - I am in the hole $1,700.
To me this is real simple, executive management keeps their promises, doesn't give highly speculative timelines, and in the end also invests in the company.
None of the above qualities are occurring. Trials - delayed. Results of the delayed trials - also delayed. Poor communication. No true personal equity in terms of stock purchases.
I have an idea.........
Since the golden quarter has come and gone, and since our management team missed this "golden quarter" without even the courtesy of some reasonable explanation -
Our CEO should show investors his confidence level by purchasing (with his own money) 100,000 shares in the open market.
I know if I believed in the product as much as he says he does - he can certainly open his wallet and prove it.
Naydenov Jordan G
Award of Stock Options
5/10/2016
-- 1.0M
$0 $0.00 - $0.00 5,097,242
As I already stated to you, CHUMP - that number you keep touting was stock options. Meaning, there was no money spent. It was free. No cash. No purchase. Look it up. No insider buying. None.
You are right, it is very quiet.... Still no insider buying, still no PR, and still ambiguous management with fantastical timelines.
Again, if this product is going to change HIV - how come not one actual insider purchase? Nader doesn't have .63 cents for a share? I mean he has destroyed the price with his dilutions, free stock options to everyone, and timeline misses.
Uh, no.....
The single largest insider purchase I see was from Carl Dockery in June of 2015.
He bought 140.8K shares at .50 cents each. He hasn't sold any because he is still in the money. total purchase was approximately $71,000
Everything else is one small purchase by the CEO, and two small purchases by the CFO.
This is my last post as I can only do three since I am new. Can anyone besides this chump guy who apparently has no facts actually answer my question?
I appreciate it. Just trying to understand the reasoning here. It makes literally no sense whatsoever.
ok. however....
But that still does not answer my question. lol
Why is there literally no insider buying? I mean it is practically nonexistent.
I am not questioning the company, but if the executive team really had confidence they would be buying. I would.
Hi
I am new here, and I have a few thousand shares of CYDY. Nothing nuts.
I am however wondering if this drug was on verge of changing the world of HIV, how come minus a "token" purchase by the CFO last year not one executive made any purchases of the stock with their own money?
Call me skeptical, but if this was my baby and I thought it would have amazing success I would be buying every share I could.
I am not short, and I am not doing anything wrong. I am simply asking a question that has puzzled me on this one.